New hope for kidney transplant patients: drug may reduce rejection and diabetes risk
Disease control
Completed
This study tested a new drug called tegoprubart in 127 people receiving their first kidney transplant. The goal was to see if it works better than the standard drug tacrolimus at preventing organ rejection while possibly causing fewer side effects like new-onset diabetes. Partici…
Phase: PHASE2 • Sponsor: Eledon Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 11:33 UTC